{
  "drug_name": "Alteplase",
  "url": "https://wikem.org/wiki/Alteplase",
  "scraped_at": "2026-01-10T02:56:06.239060",
  "sections": {
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Acute_MI": {
          "text": ">67kg: 15mg IV over 1-2min; then 50mg IV over 30min; then 35mg over next 60min (i.e. 100mg over 1.5hr)\nâ‰¤67kg: 15mg IV over 1-2min; then 0.75 mg/kg (max 50mg) IV over 30 min; then 0.5 mg/kg over 60min (max 35 mg)",
          "tables": []
        },
        "Acute_ischemic_stroke": {
          "text": "0.9mg/kg IV (max 90mg total)\n10% of dose is administered as bolus; rest is given over 60 minutes",
          "tables": []
        },
        "Massive_PE": {
          "text": "Stable Massive PE: 100mg IV over 2 hr\nOR\n0.6mg/kg over 2 min\nCardiac arrest: 50mg IV over 2 min followed by 50mg IV after 15 min if needed",
          "tables": []
        },
        "Arterial_thrombosis": {
          "text": "1.5 mg/hour by transcatheter intra-arterial infusion until lysis of thrombus",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "PE\n: 0.5 mg/kg/hour IV, for a maximum of 6 hours, in addition to heparin",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "PE",
          "url": "https://wikem.org/wiki/PE"
        }
      ]
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk\n: Infant risk cannot be ruled out\nRenal dosing: not defined\nHepatic dosing: not defined",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nBleeding diathesis\nActive internal bleeding\nCurrent intracranial hemorrhage, subarachnoid hemorrhage\nIntracranial neoplasm, arteriovenous malformation, aneurysm, or other conditions that may increase the risk of intracranial bleeding\nRecent (<3 mo) intracranial or intraspinal surgery\nRecent (<3 mo) serious head trauma\nRecent (<3 mo) stroke (for patients being treated for MI or PE)\nSevere uncontrolled hypertension",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Intracranial hemorrhage - see\nPost-tPA Hemorrhage in CVA\nGI bleed\nPericardial effusion, pericarditis, cardiac tamponade\nStroke, seizure\nPulmonary edema, pleural effusion\nCardiac dysrhythmia\nAnaphylaxis or angioedema\nStop tPA immediately\nEpinephrine 0.3 mg IM\nFamotidine 40 mg IV\nDiphenhydramine 50 mg IV\nMethylprednisolone 125 mg IV\nConsider early airway management PRN",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Post-tPA Hemorrhage in CVA",
          "url": "https://wikem.org/wiki/Post-tPA_Hemorrhage_in_CVA"
        }
      ]
    },
    "Pharmacology": {
      "text": "Onset of action: 30-60 minutes\nHalf-life: 26.5 to 46 minutes\nMetabolism: Liver\nExcretion:",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}